<DOC>
	<DOC>NCT00553605</DOC>
	<brief_summary>This is a multicenter, randomized, double blind, double dummy, comparative, active-controlled trial designed to assess the analgesic activity and safety of intravenous doses of parecoxib 40 mg relative to intravenous doses of ketoprofen 100 mg for the treatment of renal colic in outpatients presenting at emergency room settings. This trial is designed to show non-inferiority of parecoxib related to ketoprofen.</brief_summary>
	<brief_title>Efficacy And Safety Of Parecoxib 40mg vs. Ketoprofen 100mg In The Management Of Acute Renal Colic</brief_title>
	<detailed_description />
	<mesh_term>Colic</mesh_term>
	<mesh_term>Renal Colic</mesh_term>
	<mesh_term>Ketoprofen</mesh_term>
	<mesh_term>Parecoxib</mesh_term>
	<criteria>Patient male or female with a confirmed diagnosis of acute renal colic with moderate to severe pain according to the VAS and Categoric pain scales The patient has significant renal or hepatic conditions other than uncomplicated kidney stones. The patient has a history of clinically significant hypersensitivity to any NSAIDs, cyclooxygenase inhibitors, analgesics or sulfa medications which has a cross sensitivity to the medications used in this study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Renal Colic Pain Urinary Tract Colic</keyword>
</DOC>